Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Disorders of ornithine metabolism (ICD-10 Code: E72.4)
Summary
Disorders of ornithine metabolism are rare genetic conditions that disrupt the body’s ability to process ornithine, an amino acid involved in the urea cycle and other metabolic pathways. These disorders can lead to the accumulation of toxic byproducts or deficiencies in essential compounds, potentially affecting neurological, hepatic, or renal function. The clinical presentation varies depending on the specific defect but often involves metabolic imbalances and systemic complications.
Causes
These disorders are primarily caused by genetic mutations that impair enzymes or transport proteins involved in ornithine metabolism. Most are inherited in an autosomal recessive pattern, requiring two mutated copies of a gene for the condition to manifest. The mutations disrupt normal biochemical pathways, leading to abnormal ornithine levels or byproduct accumulation.
Risk Factors
- Family history of ornithine metabolism disorders.
- Consanguinity (parents who are close relatives) increasing the likelihood of inheriting recessive mutations.
- Ethnic or geographic prevalence of specific genetic variants in certain populations.
Symptoms
- Neurological symptoms such as developmental delays, seizures, or intellectual disability.
- Gastrointestinal issues like vomiting, poor feeding, or failure to thrive.
- Hepatic or renal dysfunction.
- Metabolic crises, including hyperammonemia (elevated ammonia levels).
Diagnosis
Diagnosis typically involves a combination of clinical evaluation, biochemical testing (e.g., measuring amino acid levels in blood or urine), and genetic testing to identify mutations in ornithine metabolism-related genes. Additional tests may include liver or kidney function assessments to evaluate systemic involvement.
Treatment Options
Treatment focuses on managing symptoms and preventing complications, often through dietary modifications (e.g., restricting protein intake), medications to reduce toxic byproduct accumulation, and supportive care for neurological or organ-specific issues. In severe cases, liver transplantation may be considered.
Prognosis and Follow-Up
Prognosis varies depending on the severity of the disorder and the timeliness of intervention. Early diagnosis and adherence to treatment can improve outcomes, but some individuals may experience long-term neurological or organ damage. Regular follow-up with metabolic specialists is essential to monitor metabolic status and adjust therapies as needed.
Complications
- Neurological damage from untreated hyperammonemia.
- Hepatic or renal impairment due to metabolic stress.
- Developmental delays or intellectual disability.
- Recurrent metabolic crises if treatment is not maintained.
Lifestyle & Prevention
- Adherence to prescribed dietary restrictions and medical therapies.
- Avoidance of triggers that may exacerbate metabolic imbalances (e.g., prolonged fasting, certain medications).
- Genetic counseling for families to understand inheritance risks and reproductive options.
When to Seek Professional Help
Seek immediate medical attention for symptoms of metabolic crisis, such as lethargy, seizures, vomiting, or altered consciousness. Regular follow-up with a metabolic specialist is recommended for ongoing management and monitoring.
Tips for Medical Coders
Document the specific type of ornithine metabolism disorder (if known) and any associated complications. Ensure clinical documentation supports the diagnosis, including relevant lab results or genetic testing. Use this code for conditions directly related to ornithine metabolism disorders; do not use it for unrelated metabolic or genetic conditions.
Medical Policies and Guidelines
Related policies from health plans
E72.4 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.